Portfolio (Quarterly)
Guide ↗
STEMPOINT CAPITAL LP
· CIK 0001952142| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 21 | SYRE | SPYRE THERAPEUTICS INC | Healthcare | 167,606.0 | $8.5M | 1.62% | NEW | — | $50.44 | +32.1% |
| 22 | DNLI | DENALI THERAPEUTICS INC | Healthcare | 426,561.0 | $8.2M | 1.57% | NEW | — | $19.20 | -5.7% |
| 23 | XENE | XENON PHARMACEUTICALS INC | Healthcare | 140,755.0 | $8.2M | 1.57% | NEW | — | $58.15 | -7.1% |
| 24 | CLDX | CELLDEX THERAPEUTICS INC NEW | Healthcare | 254,267.0 | $8.1M | 1.54% | NEW | — | $31.72 | -4.9% |
| 25 | PTGX | PROTAGONIST THERAPEUTICS INC | Healthcare | 72,577.0 | $7.6M | 1.46% | NEW | — | $105.40 | -6.7% |
| 26 | TYRA | TYRA BIOSCIENCES INC | Healthcare | 193,177.0 | $7.4M | 1.42% | NEW | — | $38.30 | -11.8% |
| 27 | DNTH | DIANTHUS THERAPEUTICS INC | Healthcare | 85,502.0 | $7.2M | 1.37% | NEW | — | $83.92 | +2.1% |
| 28 | CELC | CELCUITY INC | Healthcare | 60,062.0 | $6.9M | 1.31% | NEW | — | $114.14 | +14.7% |
| 29 | DFTX | DEFINIUM THERAPEUTICS INC | Healthcare | 325,483.0 | $6.2M | 1.18% | NEW | — | $18.90 | +5.9% |
| 30 | BIOA | BIOAGE LABS INC | Healthcare | 338,654.0 | $5.9M | 1.13% | NEW | — | $17.49 | -7.9% |
| 31 | — | NEWAMSTERDAM PHARMA COMPANY | — | 180,658.0 | $5.8M | 1.11% | NEW | — | $32.01 | — |
| 32 | ACAD | ACADIA PHARMACEUTICALS INC | Healthcare | 242,566.0 | $5.4M | 1.03% | NEW | — | $22.26 | -5.9% |
| 33 | — | ASSEMBLY BIOSCIENCES INC | — | 185,435.0 | $5.1M | 0.98% | NEW | — | $27.75 | — |
| 34 | ALMS | ALUMIS INC | Healthcare | 229,566.0 | $5.1M | 0.97% | NEW | — | $22.03 | +0.0% |
| 35 | NRIX | NURIX THERAPEUTICS INC | Healthcare | 315,226.0 | $4.9M | 0.94% | NEW | — | $15.50 | -1.7% |
| 36 | — | ZURA BIO LTD | — | 753,520.0 | $4.5M | 0.86% | NEW | — | $5.95 | — |
| 37 | EVMN | EVOMMUNE INC | Healthcare | 193,777.0 | $4.4M | 0.84% | NEW | — | $22.63 | -6.7% |
| 38 | TNGX | TANGO THERAPEUTICS INC | Healthcare | 200,919.0 | $4.2M | 0.81% | NEW | — | $20.92 | -3.0% |
| 39 | SNSE | SENSEI BIOTHERAPEUTICS INC | Healthcare | 132,873.0 | $4.2M | 0.80% | NEW | — | $31.52 | -44.2% |
| 40 | RLMD | RELMADA THERAPEUTICS INC | Healthcare | 597,409.0 | $4.2M | 0.80% | NEW | — | $6.96 | +1.0% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
99.3%
Financial Services
0.7%